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The Ff family of filamentous bacteriophages infect gram-negative bacteria, but do not cause
lysis of their host cell. Instead, new virions are extruded via the phage-encoded pIV protein,
which has homology with bacterial secretins. Here, we determine the structure of pIV from
the f1 filamentous bacteriophage at 2.7 Å resolution by cryo-electron microscopy, the first
near-atomic structure of a phage secretin. Fifteen f1 pIV subunits assemble to form a gated
channel in the bacterial outer membrane, with associated soluble domains projecting into the
periplasm. We model channel opening and propose a mechanism for phage egress. By single-
cell microfluidics experiments, we demonstrate the potential for secretins such as pIV to be
used as adjuvants to increase the uptake and efficacy of antibiotics in bacteria. Finally, we
compare the f1 pIV structure to its homologues to reveal similarities and differences between
phage and bacterial secretins.
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The Ff family of filamentous bacteriophages includes f1, fdand M13, and is one of the simplest biological systemsknown1. Filamentous phages such as Ff have many uses in
biotechnology2; examples include as a cloning vector, and in
phage display for screening protein-ligand and protein-protein
interactions. Ff is also increasingly employed in nanotechnology,
being engineered to adopt a variety of different forms such as
nano-wires, nanorings and branched structures3,4. With the
recent, and much publicised, global antimicrobial resistance
crisis5,6, there has been a renewed campaign in exploring the use
of phages and their proteins to target pathogenic bacteria7,8.
Understanding the structural and functional details of phage
lifecycles is thus of broad interest for both fundamental and
applied biological science research.
Phages f1, fd and M13 share 98.5% sequence identity and infect
the gram-negative bacterium Escherichia coli. The primary
binding receptor is the F-pilus - a long filamentous appendage
assembled on the bacterial cell surface. Phage virions are 1 µm
long and 6–7 nm wide, with a circular single-stranded DNA
genome encoding for 11 phage proteins. The phage genome is
encapsulated within several thousand copies of the major phage
coat protein pVIII and is capped by protein complexes consisting
of pIII/pVI and pVII/pIX at either end9. Phages bind to the
F-pilus via the pIII/pVI cap, which is followed by pilus retraction
and binding of phage to the TolQRA complex in the host cell
cytoplasmic membrane10. The phage genome is released into the
bacterial cytoplasm, DNA is replicated and phage proteins are
expressed11. New virions are assembled and released from the cell
via a complex of three phage-encoded proteins: pI, pXI and pIV,
which form a trans-membrane complex12. pI (an ATPase) and
pXI span the cytoplasmic membrane with pIV located in the
outer membrane13.
pIV is a secretin family protein, with sequence similarity to
bacterial secretins at the core of the Type IV pilus assembly
machinery and the Type II and Type III secretion systems14. A
number of high-resolution structures of bacterial secretins have
been determined which have allowed detailed comparisons to be
made15,16. All secretins are multimeric channel proteins, ranging
in molecular weight from 670 kDa to >1 MDa. Reports of stoi-
chiometry range between twelve and fifteen subunits per complex,
divided into a number of different domains. The C-terminal
domain integrates into the bacterial outer membrane and forms a
double-walled ß-barrel with a central gate forming a stricture at
the centre17. Varying numbers of soluble N-domains connect to
the ß-barrel and project into the periplasm. The N-domains are
often poorly ordered in cryo-electron microscopy (cryoEM)
structures, presumably due to their flexibility. Type II secretins
can also differ at the externally-exposed side of the ß-barrel, with
Vibrio-type complexes possessing a cap gate and Klebsiella-type
lacking this feature15. A cryoEM structure of the f1 pIV (f1pIV)
protein determined at 22 Å resolution18 showed a barrel-like
complex with a large pore running through the centre containing
a pore-gate.
We present here the cryoEM structure of the closed state of
f1pIV to 2.7 Å resolution, the first near-atomic resolution struc-
ture of a phage secretin protein. Based on the conserved nature of
secretins, we computationally model the open state f1pIV struc-
ture and its interaction with phage. By correlating our structures
to phenotypic data on f1 and f1pIV, we propose a mechanism for
phage egress. We also employ a mutant of f1pIV that produces a
leaky E. coli phenotype and demonstrate by single-cell micro-
fluidics that the macrolide antibiotic roxithromycin is taken up
efficiently by the f1pIV-expressing bacteria. The f1pIV atomic
structure is used to interpret our findings, which have important
translational implications for the use of secretins as therapeutic
adjuvants to increase antibiotic delivery to bacteria. Finally, we
reveal the common structural motifs shared by f1pIV and bac-
terial secretins, and differences in their electrostatic surface
charges and modular architecture.
Results
Structure of the f1pIV secretin. The 670 kDa f1pIV secretin
channel was expressed recombinantly in E. coli and purified in
the presence of CHAPS detergent by Ni2+ affinity and size
exclusion chromatography. Pure protein was identified by SDS-
PAGE, Western blot and mass spectrometry analysis (Supple-
mentary Fig. 1). CryoEM data were collected and processed in
Relion 3.119 (Supplementary Table 1). Averaging the protein
particles together in 2D showed that f1pIV particles are com-
posed of fifteen identical subunits (Fig. 1a); no variation in
symmetry was observed. 3D reconstruction produced a 2.7 Å map
with C15 symmetry applied (Fig. 1b and Supplementary Fig. 2).
The N-terminal part of f1pIV is comprised of two periplasmic
N domains: the far N-terminal N0 domain (residues 1–88) and
the N3 domain (108–172), which are joined together with a 19-
residue linker (89–107) (Fig. 2a). The N3 domain links to the
C-terminal secretin domain (175–405) via a two amino acid
linker (173–174) (Fig. 2a). The quality of our map allowed the N3
and secretin domains to be unambiguously modelled into the
density (Figs. 1c and 2b, c), with clear side chain densities visible
in most areas (Fig. 2d). The fifteen subunits pack against each
other to form the secretin channel, with each subunit contribut-
ing a four-stranded ß-sheet to the multimer, culminating in a
large ß-barrel composed of 60 ß-strands (Fig. 2b, c). The ß-sheets
lie at an angle of 41° relative to the central axis of the pore.
Within the ß-barrel is a smaller inner barrel comprised of four ß-
strands from each f1pIV subunit (Fig. 2c, e–g). The inner ß-barrel
is angled parallel to the pore axis and provides a scaffold for two
extended loops that reach into the centre of the pore, known as
Gate 1 and Gate 220 (Fig. 2c, g). The interface between the outer
and inner ß-barrels is composed mostly of hydrophobic residues,
and strengthened further with a salt bridge between Glu 185 and
Arg 337 (both residues are highly conserved amongst homo-
logues) (Fig. 2e, Supplementary Figs. 3 and 4). Extensive
hydrogen bonds are formed in the inner and outer ß-barrels;
within each individual subunit, and also between each subunit
and its immediate neighbours (Fig. 2f). In the outer ß-barrel,
subunit 1 forms 28 intra-subunit mainchain hydrogen bonds, and
20 inter-subunit mainchain hydrogen bonds (10 with each
neighbouring subunit). In the inner ß-barrel and gate, subunit
1 forms 34 intra-subunit mainchain hydrogen bonds and 16
inter-subunit ones (8 with each neighbouring subunit). The
interface between neighbouring N3 domains is mostly hydro-
phobic, and no hydrogen bond interactions are observed between
them in our structure. For reasons of flexibility (Supplementary
Fig. 2), the extracellular part of the ß-barrel was missing
interpretable density (36 amino acid residues, positions
199–234) as well as the very centre of the pore in the Gate 1
loop (15 residues, positions 275–289).
The f1pIV secretin measures 96 Å from the extracellular face of
the ß-barrel to the N-terminus of the N3 domain, and 112 Å
across at its widest point (within the ß-barrel). The diameter
across the inner ß-barrel is 90 Å. The pore width is constricted
further in two areas; at the central gate (40 Å) and at the N3
domains (74 Å). There are however disordered loops in both the
N3 domain and Gate 1, both pointing into the centre of the pore,
so these distances could be smaller.
The globular N3 domain consists of 65 residues which fold to
form a three-stranded ß-sheet packed against two α-helices,
joined by the short two amino acid linker to the ß-barrel (Fig. 2a,
b, c, g). The far N-terminal N0 domain and its associated 19
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residue linker region (residues 1–107, Fig. 2a) could not be
observed in our structure. In the 2D classes, a hazy area could be
seen in the expected region, suggesting that N0 could be present
but extremely flexible (Fig. 1a, red arrow). Tryptic digest mass
spectrometry was used to confirm that all of the regions for which
we either did not see density, or could not interpret the density,
were physically present (Fig. 2a).
To provide insight into the structure of the N0 domain, we
employed four complementary methods. We performed a Blast
search of f1pIV N0 plus the associated linker region (residues
1–107) against all structures in the Protein Data Bank. This
resulted in a single hit for the PulD secretin from Klebsiella
pneumoniae (6HCG)21 with 33% sequence identity over 63
residues. We used this structure to produce a homology model of
the f1pIV N0 domain in Swiss-Model22. The same f1pIV N0-
linker domain sequence was also submitted to the I-TASSER23,
Robetta24 and AlphaFold 225 structural prediction servers. The
resulting models from all methods were compared and seen to be
in agreement for the folded domain (residues 2–71; Supplemen-
tary Fig. 5a). The N0 domain is thus most likely formed by two α-
helices, flanked by a two-stranded β-sheet on one side and a
three-stranded β-sheet on the other. We used the structure from
I-TASSER to generate a composite model with our f1pIV
structure (Fig. 2g). Three key residues in the N0 domain have
been identified as important for mediating the interactions with
the periplasmic domains of pI/pXI: Met 526 and Glu 4 combined
with Ile 6927. Mapping these residues to the N0 domain shows
that they are predicted to lie at the face of N0 which would be
directly opposed to pI/pXI in the cytoplasmic membrane
(Supplementary Fig. 5b).
The four N0 models diverge at residues 72–107, which is in
agreement with this region being a flexible linker (Fig. 2a,
Supplementary Fig. 5a). The linker region has been modelled in a
fully extended conformation and the position of the N0 domain
obtained by overlaying the f1pIV structure with that of the
Klebsiella PulD secretin (6HCG21, Supplementary Fig. 5c); the
distance between N0 and N3 could be closer if the linker takes on
a more compact structure. The entire length of f1pIV (from the
extracellular face of the β-barrel to the N-terminal periplasmic
domain of N0) in our composite model is 220 Å. This agrees well
with the distance needed for f1pIV to cross the E. coli periplasm
(with a width of 210 Å)28 and reach the pI/pXI proteins in the
cytoplasmic membrane.
Membrane integration of f1pIV. An additional band of density


















Fig. 1 f1pIV cryoEM data and atomic model. a Left, 2D class averages from Relion. A red arrow highlights a hazy area, likely resulting from protein
flexibility. Right, a cross-section through the initial 3D model from Relion (generated without symmetry applied), highlighting the observed C15 symmetry
(yellow arrows), displayed using IMOD72. b Final 3D reconstruction shown from left to right as top view, side view and side view sliced through the centre.
c f1pIV protein structure modelled into the experimental density map shown as a top view, side view and side view sliced through the centre. A single f1pIV
subunit is shown as a cyan cartoon with the remaining 14 subunits in yellow; the EM map is shown in light grey. A band of 3-[(3-cholamidopropyl)
dimethylammonio]-1-propanesulphonate (CHAPS) detergent molecules is shown as purple sticks.
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Fig. 2 Structural details of f1pIV. a Domain structure and amino acid sequence of f1pIV, showing the N0 domain (dark grey), the N3 domain (blue), and
the β-barrel secretin domain (light grey). The regions forming the outer β-barrel are shown in pink, and that forming the inner β-barrel in cyan. Residues
highlighted in yellow in the amino acid sequence were observed in the cryoEM map. Underlined residues were confirmed to be present in the cryoEM
sample by mass spectrometry analysis. b Cartoon representation of the f1pIV multimer (top and side views) with a single molecule coloured as follows: N3
domain in blue, outer β-barrel in pink, inner β-barrel in cyan, Gate 1 in orange, Gate 2 in green, and CHAPS molecules as purple sticks. c Cartoon
representation of the f1pIV multimer with all chains coloured as in b. CHAPS molecules have been removed for clarity. d Residues 292–303 (incorporating
part of the Gate 1 loop and the inner β-barrel) showing representative density. e The interface between the inner and outer β-barrels is lined mostly with
hydrophobic residues which are shown as sticks, and coloured by atom (N in blue, O in red, S in yellow). A salt bridge is formed at the edge of this interface
between conserved residues Glu 185 and Arg 337 (dashed blue line). f Inter- (blue dashed lines) and intra- (red dashed lines) subunit hydrogen bonds are
formed connecting the inner and outer β-barrels. One subunit (position 1) is coloured as in b, and the neighbouring subunits (in positions 2 and 15) are
shown in grey. Only mainchain hydrogen bonds are shown; images have been clipped for clarity. g Composite model of a single f1pIV subunit shown as
front and side views. The structure built into the EM map is coloured as in b, with a homology model of the N0 domain in dark grey.
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approximately the centre of the surface of the ß-barrel (Fig. 3a).
This formed a ring around the outside of the secretin domain,
reminiscent of detergent belts typically seen in cryoEM structures
of membrane proteins29. We modelled the detergent CHAPS,
used during purification, into this density. Two molecules of
CHAPS were observed to bind to each f1pIV subunit, forming a
circle of detergent around the barrel (Fig. 3b). The detergent
molecules were bound to a ring of aromatic residues (Phe 184,
Tyr 359, and Tyr 394), forming an aromatic girdle. An additional
aromatic girdle was observed nearer the extracellular region of the
ß-barrel formed by Phe 194 and Phe 196. Such clusters of aro-
matic residues are often observed at the lipid–water interface in
membrane-spanning ß-barrels of gram-negative bacteria, and
allow for protein positioning in the membrane30. Colouring the
surface of f1pIV by hydrophobicity confirms that the two aro-
matic girdles lie within the two main regions of high hydro-
phobicity on the protein surface (Fig. 3c).
The Gate region. The inner ß-barrel, Gate 1 and Gate 2 loops
form the full gate region that projects into the pore. The Gate 1
loops extend to the centre, presumably sealing the channel
(Fig. 2g). Sequence alignments show high sequence conservation
for Gate 1 amongst secretin homologues, while Gate 2 is less well
conserved (Supplementary Fig. 3). In both cases, the areas of
highest sequence conservation are found where the gates join the
inner ß-barrel, with the more variable regions lying in the loop
regions which face the centre of the pore. There are two highly
conserved glycine residues (Gly 267 and Gly 297 in f1pIV) found
at the boundary of Gate 1, which are believed to form a hinge for
gate opening31 (Supplementary Fig. 3, Fig. 4a). An extensive
hydrogen bonding network was observed within the gate region
(Fig. 4a). Hydrogen bonds are formed within each gate (6
mainchain intra-gate bonds in Gate 1, and 3 mainchain intra-gate
bonds in Gate 2), tethering each loop together tightly. As seen in
all other secretin structures to date, the Gate 1 loop has an
unusual twisted conformation. Inter-gate hydrogen bonds are
formed between neighbouring subunits, with Gate 1 from one
chain forming four mainchain hydrogen bonds (including the
hinge residues) with Gate 2 from the neighbouring subunit
(Fig. 4a). Specific residues add further stability to the gate region.
For example, a highly conserved Arg 293 in Gate 1 forms
hydrogen bonds with the side chain of Asn 269 within the same
gate (conserved in phage secretins), and with the backbone car-
bonyl oxygen of an unconserved Val 332 from Gate 2 of the
neighbouring subunit (Fig. 4b, Supplementary Fig. 3). As Asn 269
is conserved mostly amongst phage but not bacterial secretins, we
also analysed the role of this residue in context of the pIV
structure. Asn 269 forms 4 hydrogen bonds – one each with Arg
293 and Asn 295 within the Gate 1 loop, and two with Thr 334
from the Gate 2 loop of the neighbouring subunit, demonstrating
the role of this residue in promoting a high level of stability.
Opening the f1pIV channel. The f1pIV pore must undergo
significant structural rearrangements to allow phage to egress. To
provide insight into the mechanism of channel opening, we
compared our f1pIV structure to existing closed and open gate
structures of a homologous protein: the Type III secretin InvG
from Salmonella typhimurium (6PEE and 6Q15)32. Structural
alignment of the two InvG structures highlights the main dif-
ferences between the open and closed states (Supplementary
Fig. 6). The core of the secretin domain and the conformation of
the loops remain similar; differences are seen in the position of
the gate loops relative to the barrel, the ß-lip and an extended
loop in the N3 domain. Both gate loops move to pack against the
outer ß-barrel in the open form. The Gate 1 loop moves with a
hinge-like motion, while the Gate 2 loop twists. The ß-lip at the
extracellular edge of the ß-barrel also moves away from the centre
of the pore in the open structure, and there is movement of an
extended loop (not present in f1pIV) in the N3 domain. Our














Fig. 3 Positioning of the f1pIV multimer in the E. coli outer membrane. a The f1pIV cryoEM map in side view (yellow) shows density that was
unaccounted for after the atomic model had been built (purple). b The f1pIV atomic model is shown as space-filled atoms in light grey with the CHAPS
shown as purple sticks. There are two bands of aromatic residues shown in yellow (aromatic girdles). The enlarged panels (blue boxes) show the two
girdles in greater detail with the aromatic residues labelled. One full molecule of CHAPS, and one consisting only of the aromatic rings (CHAPS*) were
modelled in to the ring of density. CHAPS is shown as purple sticks, and the f1pIV subunits are coloured as in Fig. 2b. c f1pIV atomic model shown as
surface representation is coloured by hydrophobicity, ranging from the most hydrophilic areas (dark cyan), through white, to the most hydrophobic areas
(orange).
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Fig. 4 The Gate region, channel opening, and interaction with phage. a Extensive inter- (blue dashed lines) and intra- (red dashed lines) gate hydrogen
bonds are formed between neighbouring subunits and within Gate 1 and Gate 2, colouring as in Fig. 2b. Only main chain hydrogen bonds are shown.
b Close up to show the hydrogen bonding interactions of Arg 293 and Asn 269 in Gate 1. Arg 293 forms intra-gate hydrogen bonds with Asn 269, and
inter-gate hydrogen bonds with Val 332 in Gate 2 of the neighbouring subunit. Asn 269 forms intra-gate hydrogen bonds with Arg 293 and Asn 295 in
Gate 1, and two inter-gate bonds with Thr 334 from the Gate 2 loop of the neighbouring subunit. Gate 1 from subunit 1 is shown in orange and Gate 2 from
subunit 15 in grey, and coloured by atom (N in blue, O in red). c Structural superimposition of a single f1pIV subunit closed state structure (pink) with f1pIV
modelled in the open gate position (green), shown in front, side and back views. d Close up showing the Gate 1 (Gly 267, Gly 297) and Gate 2 (Asp 321,
Asn 335) hinge residues in blue. e The closed (pink) and open (green) multimers are shown as space-fill representation in top view. f Left, structure of an
fd virion (2C0W) in cartoon form. Centre and right, manual docking of the fd virion (blue space-filled representation) into the open f1pIV secretin pore
(green surface representation) in side and top views respectively. g Left, electrostatic surface potential of the fd virion coloured red for negative and blue
for positive. Centre and right, electrostatic surface potential of the closed (pink) and open (green) states of the f1pIV pore, coloured as per the fd virion.
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Root Mean Square Deviation (RMSD) of 1.051 Å (Supplementary
Fig. 6). The f1pIV closed gate loops were thus modelled into the
open form based on their position in InvG (Fig. 4c; Supple-
mentary Fig. 6).
This model reveals how the f1pIV Gate 1 would likely pivot
upwards and outwards on the highly conserved hinge residues Gly
267 and Gly 297, located at the top of the inner ß-barrel (Fig. 4a, c,
d, Supplementary Fig. 3). The twisting motion in Gate 2 could
occur around the conserved Asp 321 and Asn 335 (Fig. 4d,
Supplementary Fig. 3). These movements would move both gate
loops closer to the outer ß-barrel and thus result in an opening of
the pore from the ~40 Å measured in our closed structure to 65 Å
(Fig. 4e). To confirm that these dimensions are sufficient for
egressing phage, we docked the fibre diffraction structure of an fd
phage (2C0W)33 into the open state of f1pIV (Fig. 4f). Colouring
the phage by electrostatic potential shows a clear negative charge
on the outer surface (Fig. 4g). In contrast, the electrostatic surface
potential within the f1pIV pore is more varied. In closed and open
states, there is a band of positive charge in the area closest to the
extracellular side, followed by a band of negative charge near the
gate region. In the open state, the aperture revealed by gate
opening is mostly positively charged (Fig. 4g).
Mapping mutations to f1pIV that cause a leaky E. coli phe-
notype. Wild type E. coli cells (strain K12) cannot transport the
bile salt deoxycholate across their outer membranes, and those
which are deficient in the LamB maltoporin cannot transport
large maltooligosaccharide sugars. Previous studies20,34,35 have
revealed a number of mutations in the f1pIV protein that render
the pore leaky to these substrates. Atomic-level detail of the f1pIV
structure can now be used to understand how these mutations
cause their effect. We mapped leaky mutations discovered by
random mutagenesis (Supplementary Table 2)20 on to the f1pIV
structure (Fig. 5a, b). The overwhelming majority (90%) were
found to lie in the gate region (the Gate 1 and Gate 2 loops or
inner ß-barrel). Three mutations (A121V, D123Y, G147V) con-
ferring leakiness to deoxycholate and maltopentaose were iden-
tified in the N3 domain, all at the interface closest to the inner ß-
barrel; one mutation (I183V) was observed in the outer ß-barrel
(Fig. 5a). The authors also tested susceptibility of E. coli expres-
sing different f1pIV mutants to the antibiotics vancomycin and
bacitracin (which are too large to cross the bacterial outer
membrane). By mapping these to our f1pIV structure, we can
visualise directly that all mutants which conferred antibiotic
susceptibility were located in the gate region (4 with sensitivity to
vancomycin alone, 12 with sensitivity to both vancomycin and
bacitracin) (Fig. 5b).
We used the map of f1pIV mutants to understand more about
the delicate balance of interactions in the gates (Supplementary
Table 2). The conserved Gate 1 hinges (Gly 267 and Gly 297) pack
closely together within the inner ß-barrel (Fig. 4d). Changing Gly
267 or Gly 297 to any other sidechain in the model causes steric
clashes. Hinge mutations would thus disrupt the packing in the
region, interfere with hinge motion and prevent proper gate
closure. Asn 269, Arg 293, and Asn 295 in Gate 1 take part in a
tight hydrogen bonding network in the closed structure (Fig. 4b)
that differs to the other secretins analysed (e.g. in Fig. 6).
Mutations in any one of these residues results in leaky f1pIV
(Fig. 4b; Supplementary Table 2, Supplementary Fig. 7). We can
now rationalise how these mutations lead to a more open gate
structure—by disrupting the hydrogen bonding network within
the Gate 1 loop and between two neighbouring gates.
Antibiotic uptake through an f1pIV leaky mutant. The anti-
biotic vancomycin is hydrophilic and bacitracin is amphipathic;
both are sufficiently small to pass through the open f1pIV pore
(Supplementary Fig. 8). E. coli expressing the previously char-
acterised f1pIV mutant S324G are sensitive to both
antibiotics20,36. Ser 324 is located in Gate 2, where mutation to a
glycine will destroy the hydrogen bond made between the Ser
324 sidechain and the backbone nitrogen of Ser 326 (Fig. 5c).
Mutation to a glycine could also change the position of the
peptide backbone, potentially altering the hydrogen bonds that
are currently made between the Ser 324 carbonyl oxygen and the
sidechain of Gln 328 from the neighbouring subunit, and those
made between the backbone nitrogen of Ser 324 and the carbonyl
oxygen of Ile 333 (Fig. 5c). The combined effect of these muta-
tions likely results in increased mobilisation of the gate and
improved antibiotic uptake.
Here we aimed to understand whether the uptake and efficacy
of hydrophobic antibiotics could be improved by expressing leaky
f1pIV in E. coli. Hydrophobic macrolides are often used as first-
line antibiotics, however, they are used typically to treat infections
caused by gram-positive but not most gram-negative bacteria due
to slow uptake across the outer membrane37. The macrolide
antibiotic roxithromycin is widely clinically employed38, and our
modelled open gate structure reveals that it is sufficiently small to
pass through the open f1pIV channel unhindered (Supplemen-
tary Fig. 8). Using single-cell analysis with the microfluidic
mother machine and time-lapse microscopy39,40, bacteria were
injected into channels and the accumulation of fluorescent
antibiotics measured41. Specifically, we employed a recently
introduced fluorescent derivative of roxithromycin (roxithromy-
cin linked to nitrobenzoxadiazole-roxithromycin-NBD), which
largely maintains the antibiotic potency of the parental drug37.
Accumulation of roxithromycin-NBD was significantly higher in
E. coli cells expressing f1pIVS324G compared to wild type f1pIV
(Fig. 5d). We also measured the minimum inhibitory concentra-
tion (MIC) for roxithromycin and determined a one-notch shift
against the mutant compared to the wild-type (64 and 96 µg/ml,
respectively). This indicates that the higher accumulation of
roxithromycin-NBD corresponds to a higher efficacy of the
antibiotic in cells expressing leaky f1pIVS324G.
Structural comparison of f1pIV with other secretins. As our
structure is the first of a phage secretin at near-atomic level, we
compared f1pIV to different classes of bacterial secretins31,32,42
(Fig. 6a–c, Supplementary Fig. 9). All secretins share the same
overall architecture of the double-walled ß-barrel and the first
and last periplasmic domains (N0 and N3), but differ in the
number of additional N domains (reviewed by Filloux and
Voulhoux15). The Gate 1 and Gate 2 loops are all in similar
conformations, pointing into the centre of the pore from the
inner ß-barrel. The N3 domains are broadly similar, with the one
notable difference being an extended loop region in the Type III
InvG secretin which extends up towards the central gate area
(Fig. 6c; Supplementary Fig. 9). In general, there is increasing
disorder within domains closest to the N-terminus, and many
structures have no clear density for their N0 domains.
Differences between secretins are seen on the extracellular face
of the ß-barrel with the Vibrio-type group of Type II secretins
posessing a cap gate which forms a much narrower opening when
compared to the other open-edged ß-barrels. From sequence
analysis (Supplementary Fig. 4), we believe f1pIV will not have a
cap structure at the extracellular side of the ß-barrel, but we could
not see this region in our cryoEM map, likely for reasons of
flexibility (Supplementary Fig. 2). We are missing density for 36
residues, which is the typical size of the ß-lip domain in phage
secretins (Supplementary Fig. 4). In contrast, the bacterial Type II
secretins typically have 51–60 residues in the ß-lip region, while
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those with a cap gate have around 80 residues here. Phage
secretins are therefore expected to have a more compact ß-lip
structure than their bacterial counterparts.
At the far C terminus of the protein, the Type II and Type III
secretins have a helical domain (the S-domain) that packs against
the outside wall of the outer ß-barrel (Fig. 6c). The S-domain
binds pilotin molecules, which are essential for the assembly and/
or localisation of secretins to the outer membrane. f1pIV and the
Type IV pilus secretins do not have an S-domain, with their
respective C-termini being located at the periplasmic side of the
outer ß-barrel (Fig. 6c). Interestingly, the Type IV pilus secretins
bind to their pilotin partner via a hydrophobic girdle around the
ß-barrel, in a similar place to the central hydrophobic girdle that
we have observed in f1pIV (Supplementary Fig. 10).
We used the Consurf server43 to perform a sequence alignment













Ser 324 Ser 324 Ser 324
Ile 333 Ile 333
Ile 333




































Fig. 5 Antibiotic susceptibility in E. coli expressing leaky mutants of f1pIV. a Front and side views showing all mutants20 that were leaky to both
maltopentaose and deoxycholate as magenta sticks. b Front and side views showing the mutations which caused sensitivity to the antibiotics vancomycin
and bacitracin as green sticks. Mutations which caused sensitivity to vancomycin only are shown as orange sticks. In parts a and b the 15-residue loop from
residues G275-Q289 (labelled), which is disordered in our structure, has been modelled in for representation purposes. The position of the Ser 324
mutation to Gly (S324G), analysed in part d, is also shown. c Gate 2 loop showing the key hydrogen bonds made by Ser 324. Subunit 1 is shown in purple,
with neighbouring subunits 2 and 15 in red and green respectively. The close up shows that Ser 324 forms intra-gate hydrogen bonds with Ile 333 and Ser
326 (red dashed lines), and an inter-gate hydrogen bond with Gln 328 from a neighbouring subunit (blue dashed line) (N in blue, O in red). d Top,
individual E. coli cells expressing f1pIVS324G take up fluorescently labelled roxithromycin. No fluorescence change was observed for the cells expressing wild
type f1pIV (f1pIVWT). Scale bar, 5 μm. Bottom, scatter graph depicting the fluorescence change for f1pIVWT and f1pIVS324G samples, confirming
roxithromycin uptake in the S324G mutant. Data were analysed using an unpaired t-test with Welch’s correction. ****= p≤ 0.0001. n= 241 biologically
independent cells for f1pIVWT and n= 260 for f1pIVS324G; error bars represent standard error of the mean.
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colour them by the degree of sequence conservation (Fig. 6d). The
area of greatest conservation lies within the inner ß-barrel and the
region of outer ß-barrel that packs against it, demonstrating the
importance of this region for protein stability and/or function.
The N3 domain is more variable, likely as a result of evolution to
suit the function of the individual system. We also compared the
electrostatic surface potential between the different classes of
secretins (Fig. 6b and Supplementary Fig. 9). The outside surfaces
have a mixture of positively and negatively charged areas, with
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Fig. 6 Structural comparison of f1pIV with a selection of different classes of bacterial secretins. Secretins are aligned at the β-barrel domain. f1pIV is
shown in pink (this study:7OFH), the Type III secretin InvG from Salmonella typhimurium in sea green (6PEE), the Type II secretin GspD from E. coli K12
in yellow (Klebsiella-type, 5WQ7), the Type II secretin GspD from Vibrio cholerae in blue (Vibrio-type, 5WQ8) and the Type IV pilus secretin PilQ from
Vibrio cholerae in orange (6W6M). The secretins are shown in a) as multimers (with one subunit coloured lime green). Periplasmic N domains not
observed in the maps are shown as grey boxes. b Electrostatic surface potential comparison of multimers cut-through to show the inner surface inside the
pore. c Structural superimposition of the selected secretin subunits (shown individually in Supplementary Fig. 9) in front (left) and side (right) views.
d Sequence conservation amongst the secretin family plotted on to the f1pIV structure, calculated using Consurf and based on 100 unique homologues
from the UniProt database sharing 35–100% identity.
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membrane proteins. The surface charge inside the secretins is
quite varied; differences presumably arose to accommodate the
particular shapes and electrostatic charges of substrate that each
secretin transports.
Discussion
f1pIV is the first near-atomic resolution example of a phage
secretin. The protein has a similar overall architecture to bacterial
secretins, but differs in its electrostatic surface potential inside the
pore and in the number of N domains. f1pIV is relatively com-
pact, with no cap gate, no C-terminal S-domain, and one N3 and
one N0 domain; an arrangement which could have arisen to save
valuable space in the limited capacity of the phage genome.
The phenotypes of many previously characterised mutants can
be rationalised with our structure. f1pIV shows extensive
hydrogen bonding within the outer and inner ß-barrel domains,
as well as hydrophobic interactions and a salt bridge between the
inner and outer walls. Mutation of two conserved hydrophobic
residues at the interface to glycines (I312G and I314G) prevents
multimer formation20. In addition, inclusion of a His-tag on the
external loop between the inner and outer ß-barrels has a
destabilising effect, but this can be rescued by introducing a
hydrophobic mutation (S318I)44, which lines the interface. The
conserved hydrophobic residues between inner and outer ß-
barrels are clearly important for folding and stability, and high-
light the importance of the unusual double-walled architecture.
In order for the phage to pass through f1pIV, the central gate
must open. Our findings, alongside f1pIV phenotypic data and
the conserved architecture of the secretin family, can be used to
propose a mechanism (Fig. 7). Our data show that the
periplasmic N-terminal N0 domain is extremely dynamic. This is
likely due to the absence of the pI/pXI cytoplasmic membrane
partners, which interact with the N0 domain of f1pIV on phage
egress12,26,27. This flexibility may allow f1pIV to sample a wider
amount of periplasmic space than a rigid structure, allowing the
N0 domains to locate and bind to the cytoplasmic membrane
assembly proteins. Bearing in mind that pI/pXI interaction with
f1pIV is required for phage assembly12,26, this suggests that gate
opening may be triggered by interaction of the N0 domain of
f1pIV with the pI/pXI cytoplasmic membrane components. Both
ATP and the proton motive force are required to assemble
phage12,45, and phages with mutations in the pI protein Walker A
motif are non-functional for assembly12. It is thus tempting to
speculate that interaction of the pIV N0 domain with the peri-
plasmic domain of pI/pXI could result in energy transfer from the
pI ATPase to help drive phage egress. The egressing phage will
subsequently encounter the N3 domain. Introducing mutations
into the N3 domain of f1pIV causes partial gate opening20,
highlighting its role in transducing information from the peri-
plasmic N domains into the ß-barrel. The involvement of N3 in
channel opening has also been predicted for Type II and Type III
secretins31,32,46,47.
Our model of the open state of f1pIV highlights how the
central gate loops will likely move to allow phage to egress via
conserved hinge residues. A 10 residue in-frame deletion in Gate
2 results in leaky multimers that are non-functional for phage
assembly and egress20, suggesting that passage of phage through
f1pIV is not a passive process. It is plausible that interaction of
the f1 cap proteins pVII/pIX with the f1pIV gate will be required
to fully open the pore, assisted by the force of the assembling f1



















Fig. 7 Model for filamentous phage egress. a f1pIV with the gate in the closed state (salmon pink). The N3 (blue) and N0 (yellow) domains project into
the periplasm. N0 is attached to N3 via a long linker and is flexible. b N0 (now green, activated) is bound to the cytoplasmic membrane complex of pI/pXI
(purple) with pIV (orange) primed to open. c Egressing phage (blue) interacts with the N3 domain (now green, activated), triggering opening of pIV (now
green, open) by rearrangement of the gate. The pVIII phage capsid was drawn using the 2C0W structure, and the pVII/pIX cap added as a cartoon.
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Gate 2 means that the loops do not alter their conformation
significantly, rather both loops are pivoted around their hinges.
The hydrogen bonds between neighbouring subunits means that
all gates would move synchronously.
The surface of the phage (comprised of pVIII) is negatively
charged, whereas open f1pIV contains a mixture of positive and
negative charge, with mostly positively charged residues in the
periplasmic chamber. f1pIV can tolerate a degree of variation
with respect to the pVIII coat of exported phage. For example, f1
phages with short peptides linked to the surface-exposed N-ter-
minus are produced with similar efficiency as the wild-type
phage48. There are however key residues that may be important
in maintaining specific electrostatic interactions. For example,
deletion of a predominantly negatively charged sequence (Gly3
Asp4 Asp5) from pVIII results in f1 phage that is defective in
assembly48. In addition, the leaky mutant f1pIVE292K exhibits the
highest sensitivity to antibiotics and a 10-fold decrease in phage
assembly relative to wild-type20. The negatively charged sidechain
of Glu 292 points into the lower cavity of the pore (Supple-
mentary Fig. 7). Replacing this with a positively charged lysine
residue would alter the electrostatic potential in this area,
potentially interfering with phage assembly. It is therefore likely
that a mixture of both attractive and repulsive forces are
important for phage assembly and egress, similar to the findings
reported for the assembly and rotation of the bacterial flagellar
rod49.
f1pIV shows most sequence similarity to GspD from Klebsiella
pneumoniae (Supplementary Fig. 11), and thus it is plausible that
the ancestral f1 phage captured a Type II secretin which subse-
quently evolved to meet the needs of phage assembly and egress.
Indeed, a number of filamentous phages do not encode a secretin,
but rather hijack one from their bacterial host50,51. We predict
that the outermost hydrophobic girdle in f1pIV forms the
membrane embedded domain, as has been proposed for other
secretin structures15,16,42,52. The other hydrophobic girdle (loca-
ted half way down the barrel) would then lie within the peri-
plasm, in a similar position to where pilotins are seen to bind to
other secretins (Supplementary Fig. 10)53. The fact that this
hydrophobic girdle has been evolutionarily maintained in f1pIV,
even in the absence of a phage pilotin, highlights its functional
importance. In support of this, the C-terminus of f1pIV is in close
vicinity to the girdle, and C-terminal His-tags result in non-
functional f1pIV44. In addition, chimeras of f1pIV with
C-terminal pilotin-binding S-domains from other secretins (PulD
and InvG) are only targeted to the outer membrane and func-
tional for phage assembly in the presence of their respective
pilotins (PulS or InvH)54,55. The C-terminus and hydrophobic
girdle are thus an important interaction surface, with one possi-
bility being that the phage system is able to hijack bacterial
pilotins, or pilotin-like proteins, to aid its targeting and assembly.
Uptake of hydrophilic and amphipathic antibiotics have been
tested with f1pIV previously, whereas hydrophobic drugs have
not. We demonstrate that the leaky mutant f1pIVS324G allows E.
coli to accumulate the hydrophobic macrolide roxithromycin to a
greater extent than its wild type counterpart. Ser 324 mutation to
Gly likely destroys important hydrogen bonds and alters the
position of the peptide backbone, resulting in a more open gate
structure that is non-selective to the hydrophobicity of the
molecule passing through. These findings, along with our f1pIV
atomic model and the conserved nature of secretins, supports
targeting the secretin family as an antimicrobial approach56,57.
For example, in silico and in vivo screens could be used to
identify molecules that can destabilise the gates, in effect sensi-
tising any secretin-expressing pathogen to a wide range of anti-
biotics. Phage therapy is also receiving renewed attention, and
filamentous phages have been engineered to carry lethal genes to
bacteria58–60. Leaky f1pIV could be cloned into the genome of
phages of interest, and on protein expression channels would
open in the host bacterial outer membrane, allowing antibiotics to
enter. Both of these approaches would add much needed artillery
to our library of therapeutic tools needed to combat the
increasing rise of antimicrobial resistance.
Methods
The system of amino acid numbering used throughout is for the mature wild-type
f1pIV protein (minus the 21 signal sequence residues). Standard reagents were
purchased from Sigma-Aldrich unless otherwise stated.
Bacterial strains. All bacterial strains used were E. coli K12 derivatives. TG1
electrocompetent cells were purchased from Lucigen and used for expression of
f1pIV for cryoEM studies. Strain K2040 [MC4100 ΔlamB106 degP41 (ΔPstl-KmR)]
described in ref. 20 was used for the microfluidics experiments.
Expression and purification of f1pIV. His-tagged f1pIV was recombinantly
expressed in E. coli and purified in the presence of CHAPS detergent (Melford)
based on previously published methods36,61. The wild type protein was engineered
to have a 9 residue His tag (SAHHHHHHH) inserted at position 308 and a
stabilizing S318I mutation44. Protein expression was induced with 1 mM IPTG
overnight at 20 °C and cells were lysed by sonication. The membrane fraction was
solubilized in 5% (w/v) CHAPS, 50 mM Tris pH 7.6, 500 mM NaCl, 30 mM imi-
dazole and incubated with Ni2+ Sepharose beads. f1pIV was eluted with a
0.03–1M imidazole gradient, and then further purified by gel filtration chroma-
tography on a Superose 6 Increase 10/300 GL column (GE Healthcare) in 1% (w/v)
CHAPS, 25 mM Na HEPES pH 8.0, 500 mM NaCl, 0.5 mM EDTA. Purified f1pIV
was separated on an Any kD mini-protean TGX gel (Biorad), electrophoretically
transferred to PVDF membrane and incubated with an anti-pIV antibody at 1:2000
dilution, followed by secondary goat anti-rabbit IgG (H+ L)-HRP conjugate
(Biorad) at 1:3000 dilution, which was detected by ClarityTM Western ECL sub-
strate (Biorad).
CryoEM grid preparation and data collection. The f1pIV purified sample (3 µl of
~0.7 mg/ml) was applied to graphene oxide-coated lacey carbon grids, 300 mesh
(Agar Scientific) without any glow discharge, and frozen on a Mark IV Vitrobot
(Thermo Fisher Scientific, 4 °C, 100% relative humidity, blot force 0, blot time 4 s).
Micrographs were collected on a 300 kV Titan Krios microscope (Thermo Fisher
Scientific) with a K3 direct electron detector (Gatan) at the Electron Bio-imaging
Centre (eBIC) at Diamond Light Source, UK. Data were collected using EPU
software (Thermo Fisher Scientific) with a pixel size of 1.072 Å (0.536 Å super-
resolution) and a defocus range from −2.5 µm to −1.3 µm. Further details are
shown in Supplementary Table 1. A subset of data was collected in normal mode
(dataset 1), and a second subset in super-resolution mode (dataset 2).
CryoEM image processing. Warp62 was used for motion correction, CTF cor-
rection and particle picking. 241,591 particles were picked from 7,037 micrographs
for dataset 1 and 330,389 from 14,336 for dataset 2. Both sets of data were pro-
cessed separately and combined in the latter stages of data processing. Several
rounds of 2D classification and 3D refinement were implemented in Relion19
followed by CTF refinement and polishing steps. The statistics of data collection
and model reconstruction are shown in Supplementary Table 1, and data quality
checks63,64 are shown in Supplementary Fig. 2.
Model building and refinement. A homologous structure of the Type II secretin
GspD from enteropathogenic Escherichia coli (5W68)52 was manually placed in the
cryoEM map using Chimera65. Subsequent building and model adjustments were
performed using Coot66. Bulky residues, glycine residues, and unique sequence
patterns were used to guide sequence assignment during model building. 15-fold
symmetry was applied in Chimera, and the multimeric structure was refined using
Refmac from the CCPEM suite67, with the quality of the model evaluated using the
validation tools in Coot and Molprobity68. DeepEMhancer69 was used for
denoising and postprocessing of the maps, which were then analysed to check for
additional information that could be modelled from the improved maps. A Fourier
Shell Correlation (FSC) curve showing the quality of the model to map fit (cal-
culated with Phenix)64 is shown in Supplementary Fig. 2.
Mass spectrometry analysis. A sample of f1pIV was run on an SDS-PAGE gel
(Any kD mini-protean TGX, Biorad), stained with Coomassie, and the band of
interest excised with a sterile scalpel blade. The gel band was subjected to in-gel
tryptic digestion using a DigestPro automated digestion unit (Intavis Ltd.) and the
resulting peptides were fractionated using an Ultimate 3000 nano-LC system in line
with an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific). In brief,
peptides in 1% (vol/vol) formic acid were injected onto an Acclaim PepMap C18
nano-trap column (Thermo Scientific). After washing with 0.5% (vol/vol)
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acetonitrile 0.1% (vol/vol) formic acid peptides were resolved on a 250 mm × 75 μm
Acclaim PepMap C18 reverse phase analytical column (Thermo Scientific) over a
150 min organic gradient, using 7 gradient segments (1–6% solvent B over 1 min.,
6–15% B over 58 min., 15–32% B over 58 min., 32–40% B over 5 min., 40–90% B
over 1 min., held at 90% B for 6 min and then reduced to 1% B over 1 min.) with a
flow rate of 300 nl min−1. Solvent A was 0.1% formic acid and Solvent B was
aqueous 80% acetonitrile in 0.1% formic acid. Peptides were ionized by nano-
electrospray ionization at 2.2 kV using a stainless-steel emitter with an internal
diameter of 30 μm (Thermo Scientific) and a capillary temperature of 250 °C.
All spectra were acquired using an Orbitrap Fusion Tribrid mass spectrometer
controlled by Xcalibur 2.1 software (Thermo Scientific) and operated in data-
dependent acquisition mode. FTMS1 spectra were collected at a resolution of
120,000 over a scan range (m/z) of 350–1550, with an automatic gain control
(AGC) target of 400 000 and a max injection time of 100 ms. Precursors were
filtered according to charge state (to include charge states 2–7), with monoisotopic
peak determination set to peptide and using an intensity range from 5E3 to 1E20.
Previously interrogated precursors were excluded using a dynamic window
(40 s ± 10 ppm). The MS2 precursors were isolated with a quadrupole mass filter
set to a width of 1.6 m/z. ITMS2 spectra were collected with an AGC target of 5000,
max injection time of 50 ms, and HCD collision energy of 35%.
The raw data files were processed and quantified using Proteome Discoverer
software v1.4 (Thermo Scientific) and searched against the UniProt Escherichia coli
database (4349 sequences) plus the supplied amino acid sequence using the
SEQUEST algorithm. Peptide precursor mass tolerance was set at 10 ppm, and MS/
MS tolerance was set at 0.8 Da. Search criteria included carbamidomethylation of
cysteine (+57.0214) as a fixed modification and oxidation of methionine
(+15.9949) as a variable modification. Searches were performed with full tryptic
digestion and a maximum of 1 missed cleavage was allowed. The reverse database
search option was enabled and all peptide data were filtered to satisfy false
discovery rate (FDR) of 5%.
Sequence alignments and homology modelling. The sequence of the N terminal
region of the model that was not accounted for in our structure (residues 1–107)
was subjected to a Blast search70 against all sequences in the Protein Data Bank. A
sequence alignment of the top hit was performed on f1pIV with Praline71 and
Swiss-Model22 used to create a homology model of the f1pIV N0 domain. In
addition, the sequence of the f1pIV N0 domain was submitted to the I-TASSER
structural prediction server23, to the Robetta structural prediction server24, and to
the Alphafold 2 structural prediction server25. The top predicted models for all
methods were in agreement for residues 2–71 where they started to diverge. Open
and closed gate structures of InvG from Salmonella typhimurium were super-
imposed with the closed structure of f1pIV, and Gate 1 and 2 loops were modelled
into an open position using Coot. 15-fold symmetry was applied to produce a
model of the f1pIV open state.
The Consurf server43 was used to perform a sequence alignment of f1pIV
homologues (101 unique sequences with 35–100% sequence similarity from the
UniProt database were used for this analysis), map them to the f1pIV structure and
colour them by the degree of sequence conservation.
Determination of minimum inhibitory concentration. E. coli cells were freshly
transformed with plasmid pPMR132WT or pPMR132S324G and single colonies of E.
coli f1pIVWT or E. coli f1pIVS324G were picked and cultured at 37 °C in FB media
(2.5% (w/v) tryptone, 0.75% (w/v) yeast extract, 0.6% (w/v) NaCl, 0.1% (w/v)
glucose, 50 mM TrisHCl (pH 7.5)). Plasmid DNA was miniprepped and sequenced
for each experiment to ensure there had been no additional mutations. Protein
expression was induced overnight (in FB media plus 0.5 mg/ml bovine serum
albumin) with 1 mM IPTG at 20 °C, then diluted 40-fold and grown to OD600=
0.5. 60 µl of roxithromycin stock (640 µg/ml in DMSO) were added to the first
column of a 96-well plate. 40 µl of the induction media (FB media, 1 mM IPTG,
0.5 mg/ml BSA) was added to the first column, and 30 µl to all other wells. A total
of 70 µl solution was then withdrawn from the first column and serially transferred
to the next column until 70 µl solution withdrawn from the last column was
discharged. The mid-log phase cultures (i.e. OD600= 0.5) were diluted to 106
colony forming units (c.f.u.)/ml and 30 µl was added to each well, to give a final
concentration of 5 × 105 c.f.u/ml. Each plate contained two rows of 12 positive
control experiments (i.e. bacteria growing in induction media without roxi-
thromycin) and two rows of 12 negative control experiments (i.e. induction media
only). Plates were incubated at 37 °C overnight. The minimum inhibitory con-
centrations (MICs) of roxithromycin against E. coli f1pIVWT and E. coli f1pIVS324G
were determined visually, with the MIC being the lowest concentration well with
no visible growth (compared to the positive control experiments).
Single-cell microfluidics. Single-cell microfluidics experiments to measure the
intracellular accumulation of roxithromycin-NBD were carried out as previously
reported37,39,41. Briefly, overnight cultures were prepared as described above and a
50ml aliquot was centrifuged for 5 min at 2,600 × g at 37 °C and resuspended at an
OD595 of 75. A 2 μl aliquot of this suspension was injected in the microfluidic mother
machine device and incubated at 37 °C. The microfluidic device was completed by
the integration of fluorinated ethylene propylene tubing (1/32″ × 0.008″). The inlet
tubing was connected to the inlet reservoir which was connected to a computerised
pressure-based flow control system (MFCS-4C, Fluigent). The microfluidic device
was mounted on an inverted microscope (IX73 Olympus, Tokyo, Japan) and the
main microchamber of the mother machine was washed into the waste reservoir by
flowing media at 100 μl/h for 2 h. Images were collected via a 60×, 1.2 N.A. objective
(UPLSAPO60XW, Olympus) and a sCMOS camera (Zyla 4.2, Andor, Belfast, UK).
After this initial 2 h growth period in growth media, the microfluidic environment
was changed by flowing media containing roxithromycin-NBD at a concentration of
46 μg/ml. Upon acquiring a bright-field image the microscope was switched to
fluorescent mode and FITC filter using custom built Labview software. A fluores-
cence image was acquired by exposing the bacteria to the blue excitation band of a
broad-spectrum LED (CoolLED pE300white, Andover, UK) at 20% of its intensity.
Bright-field and fluorescence imaging was carried out every 10min. The entire assay
was carried out at 37 °C in an environmental chamber (Solent Scientific, Portsmouth,
UK) surrounding the microscope and microfluidics equipment. Images were pro-
cessed as previously described37,39,41.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The 3D cryoEM density maps generated in this study have been deposited in the Electron
Microscopy Data Bank (EMDB) under accession code EMD-12874. The atomic
coordinates have been deposited in the Protein Data Bank (PDB) under accession
number 7OFH. The source image data used in this study have been deposited to the
Electron Microscopy Public Image Archive (EMPIAR) under accession number
EMPIAR-10807. Source data for Fig. 5d are provided with this paper.
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